This past April, 32 NFL prospects heard their names called in the first round of the draft. In a few weeks, every one of them ...

Rob Pelinka, the Los Angeles Lakers’ president of basketball operations, vowed to build a championship-contending roster ...

Spurs are well and truly in the race to seal his signature. It would arguably be their finest coup of the whole window. Why ...

To survive in the human host, bacteria have developed many different strategies to escape the innate immune response, including the expression of an extracellular capsule and 'hiding' within host ...

This North Carolina star would be a great complement to Luka Doncic.

Hemolytic uremic syndrome (HUS) is a clinical syndrome characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure (1). In ∼90% of childhood cases, HUS follows a ...

The NBA and the draft order received major shakeups following a pair of trades late Tuesday night. Giannis Antetokounmpo will officially be moved to the Miami Heat for a handful of young players and ...

Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...

Quantified preferences favored higher lesion growth rate reduction (10%→50% at 18 months) as the primary driver across all ...

Nuvectis Pharma is downgraded from 'Strong Buy' to 'Hold' due to disappointing NXP800 data and increased execution risk. Click here to read my analysis.

Omeros Corporation (Nasdaq: OMER) announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company’s marketing ...